Walter Finkbeiner | Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel | Mesothelioma DR

24/7 Patient Assistance: 760-405-8205

Walter Finkbeiner, MD

Pathologist

Conditions Treated Asbestosis Clubbed Fingers Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma

Hospitals & Clinics

UCSF Medical Center

specialties & services

Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel

Insurance Accepted

University of Illinois College of Medicine

Medical School

University of Illinois College of Medicine at Chicago

Internship

American Board of Pathology

UCSF Medical Center

Languages: English/Spanish

(415) 353-1037

505 Parnassus Ave

San Francisco, California 94143

Dr. Walter Finkbeiner has contributed to 3 publications.

Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Phuan, P. W.,Veit, G.,Tan, J.,Roldan, A.,Finkbeiner, W. E.,Lukacs, G. L.,Verkman, A. S.; Mol. Pharmacol.. 2014 Apr 17.

Growth of alveoli during postnatal development in humans based on stereological estimation.

Herring, M. J.,Putney, L. F.,Wyatt, G.,Finkbeiner, W. E.,Hyde, D. M.; Am. J. Physiol. Lung Cell Mol. Physiol.. 2014 Jun 08.

Pivotal Role of MUC1 Glycosylation by Cigarette Smoke in Modulating Disruption of Airway Adherens Junctions In Vitro.

Zhang, L.,Gallup, M.,Zlock, L.,Chen, Y. T.,Finkbeiner, W. E.,McNamara, N. A.; J. Pathol.. 2014 May 20.

Bio & Insurance Information

Insurance Accepted

Aetna
Education & Training

University of Illinois College of Medicine
Medical School
University of Illinois College of Medicine at Chicago
Internship
Board Certifications

American Board of Pathology
Hospital & Practice

UCSF Medical Center

Languages: English/Spanish

(415) 353-1037

505 Parnassus Ave

San Francisco, California 94143
Read More
Publications & Memberships

Dr. Walter Finkbeiner has contributed to 3 publications.

Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Phuan, P. W.,Veit, G.,Tan, J.,Roldan, A.,Finkbeiner, W. E.,Lukacs, G. L.,Verkman, A. S.; Mol. Pharmacol.. 2014 Apr 17.
See more >>

Growth of alveoli during postnatal development in humans based on stereological estimation.

Herring, M. J.,Putney, L. F.,Wyatt, G.,Finkbeiner, W. E.,Hyde, D. M.; Am. J. Physiol. Lung Cell Mol. Physiol.. 2014 Jun 08.
See more >>

Pivotal Role of MUC1 Glycosylation by Cigarette Smoke in Modulating Disruption of Airway Adherens Junctions In Vitro.

Zhang, L.,Gallup, M.,Zlock, L.,Chen, Y. T.,Finkbeiner, W. E.,McNamara, N. A.; J. Pathol.. 2014 May 20.
See more >>